山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (4): 31-35.doi: 10.6040/j.issn.1673-3770.1.2019.031

• 临床研究 • 上一篇    下一篇

双氢青蒿素对下咽癌Fadu细胞内质网应激途径的作用

黄泽雷1,宋琦2,路秀英2,崔兰珍2,李晓明2,*()   

  1. 1. 河北省人民医院耳鼻喉科,河北 石家庄 050057
    2. 白求恩国际和平医院耳鼻咽喉头颈外科,河北 石家庄 050082
  • 收稿日期:2019-05-13 出版日期:2019-07-16 发布日期:2019-07-22
  • 通讯作者: 李晓明 E-mail:xmlmo@126.com

Effects of dihydroartemisinin on endoreticulum stress pathway in FaDu hypopharyngeal carcinoma cells

Zelei HUANG1,Qi SONG2,Xiuying LU2,Lanzhen CUI2,Xiaoming LI2,*()   

  1. 1. Department of otolaryngology, Hebei General Hospital, Shijiazhuang 050057, Hebei, China
    2. Department of otolaryngology, Bethune International Peace Hospital, Shijiazhuang 050082, Hebei, China
  • Received:2019-05-13 Online:2019-07-16 Published:2019-07-22
  • Contact: Xiaoming LI E-mail:xmlmo@126.com

摘要: 目的

探讨双氢青蒿素(DHA)抑制下咽癌Fadu细胞增殖的机制,为其应用于临床抗肿瘤治疗提供理论依据。

方法

应用含不同浓度葡萄糖(5.5、10、15、25、50、100 mM)培养基,培养Fadu细胞36 h,Western blot检测p-STAT3及内质网应激相关蛋白GRP78的表达情况。应用不同浓度(10、20、40、80、160 μM)DHA在培养基糖浓度为25 mM条件下处理下咽癌Fadu细胞,24 h后用MTT比色法检测对细胞增殖的影响;Western blot检测p-STAT3、GRP78的表达情况。

结果

DHA抑制下咽癌Fadu细胞增殖,且具剂量依赖性;低糖培养基可以降低p-STAT3的表达,增加GRP78的表达;DHA抑制p-STAT3表达,低浓度DHA刺激GRP78表达,随着浓度逐渐增高则抑制其表达。

结论

DHA可以显著抑制下咽癌Fadu细胞的增殖,抑制p-STAT3的表达,诱导内质网应激,其作用机制可能与干扰细胞糖代谢密切相关。

关键词: 双氢青蒿素, 下咽癌, Fadu细胞, 内质网应激

Abstract: Objective

To investigate the mechanism of inhibition by dihydroartemisinin (DHA) of the proliferation of FaDu cells in hypopharyngeal cancer, and provide a theoretical basis for its clinical application in anti-tumor therapy.

Methods

FaDu cells were cultured in different concentrations of glucose (5.5, 10, 15, 25, 50, 100 mM) for 36 h, then the expression of p-STAT3 and endoplasmic reticulum stress-related protein GRP78 were detected by western blot. FaDu cells of hypopharyngeal carcinoma were treated with DHA at different concentrations (10, 20, 40, 80, 160 M) in a culture medium with 25 mM glucose, and the effect on cell proliferation was detected by MTT assay 24 h later. Western blot was used to detect the expression of p-STAT3 and GRP78.

Results

DHA inhibited the proliferation of FaDu hypopharyngeal carcinoma cells in a concentration-dependent manner. Low-glucose concentration medium reduced the expression of p-STAT3 and increased the expression of GRP78. DHA inhibited the expression of p-STAT3; GRP78 expression was stimulated at low DHA concentrations, but was inhibited as the DHA concentration increased.

Conclusions

DHA significantly inhibits the proliferation of FaDu hypopharyngeal carcinoma cells, inhibits the expression of p-STAT3, and induces endoplasmic reticulum stress, which may be closely related to the interference of cellular glucose metabolism.

Key words: Dihydroartemisinin, Hypopharyngeal cance, Fadu cells, Endoreticulum stress

中图分类号: 

  • R739.6

图1

不同剂量的DHA作用Fadu细胞24 h结果"

图2

不同浓度葡萄糖培养基对p-STAT3、STAT3、GRP78表达的影响"

图3

不同浓度DHA对p-STAT3、STAT3、GRP78表达的影响"

1 Heng PS , Irfan M . Hypopharyngeal cancer masquerading as a thyroid mass[J]. Med J Malaysia, 2016, 71 (6): 360- 362.
2 Takes RP , Strojan P , Silver CE , et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery[J]. Head Neck, 2012, 34 (2): 270- 281.
doi: 10.1002/hed.21613
3 Cooper JS , Porter K , Mallin K , et al. National Cancer Database report on cancer of the head and neck: 10-year update[J]. Head Neck, 2009, 31 (6): 748- 758.
doi: 10.1002/hed.21022
4 Day D , Hansen AR , Siu LL . Hypopharyngeal cancer: looking back, moving forward[J]. Curr Oncol, 2016, 23 (4): 221- 222.
doi: 10.3747/co.23.3242
5 Wang DC , Meng G , Zheng MH , et al. The glutaminase-1 inhibitor 968 enhances dihydroartemisinin-mediated antitumor efficacy in hepatocellular carcinoma cells[J]. PLoS One, 2016, 11 (11): e0166423.
doi: 10.1371/journal.pone.0166423
6 Jiang J , Geng GJ , Yu XY , et al. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis[J]. Oncotarget, 2016, 7 (52): 87271- 87283.
doi: 10.18632/oncotarget.13536.10.1007/s10637-010-9481-8
7 Lu JJ , Chen SM , Zhang XW , et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells[J]. Invest New Drugs, 2011, 29 (6): 1276- 1283.
doi: 10.1007/s10637-010-9481-8
8 Zhang SQ , Ma YN , Jiang JT , et al. Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells[J]. Oncol Lett, 2014, 7 (5): 1375- 1380.
doi: 10.3892/ol.2014.1918
9 Hu CJ , Zhou L , Cai Y . Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2[J]. Cancer Biol Ther, 2014, 15 (3): 279- 288.
doi: 10.4161/cbt.27223
10 Xu G , Zou WQ , Du SJ , et al. Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis[J]. Life Sci, 2016, 157: 1- 11.
doi: 10.1016/j.lfs.2016.05.033
11 Jia LF , Song Q , Zhou CY , et al. Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 signaling[J]. PLoS One, 2016, 11 (1): e0147157.
doi: 10.1371/journal.pone.0147157
12 贾立峰, 李晓明, 申宇鹏, 等. 双氢青蒿素对下咽癌Fadu细胞凋亡的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30 (21): 1685- 1688.
doi: 10.13201/j.issn.1001-1781.2016.21.005
JIA Lifeng , LI Xiaoming , SHEN Yupeng , et al. Effects of dihydroartemisinin on the apoptosis of Fadu cells[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2016, 30 (21): 1685- 1688.
doi: 10.13201/j.issn.1001-1781.2016.21.005
13 Pi LH , Li XM , Song Q , et al. Knockdown of glucose-regulated protein 78 abrogates chemoresistance of hypopharyngeal carcinoma cells to cisplatin induced by unfolded protein in response to severe hypoxia[J]. Oncol Lett, 2014, 7 (3): 685- 692.
doi: 10.3892/ol.2013.1753
14 Teng Y , Ross JL , Cowell JK . The involvement of JAK-STAT3 in cell motility, invasion, and metastasis[J]. JAKSTAT, 2014, 3 (1): e28086.
doi: 10.4161/jkst.28086
15 Kamran MZ , Patil P , Gude RP . Role of STAT3 in cancer metastasis and translational advances[J]. Biomed Res Int, 2013, 2013: 421821.
doi: 10.1155/2013/421821
16 Lopez R , Arumugam A , Joseph R , et al. Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR[J]. PLoS One, 2013, 8 (11): e79708.
doi: 10.1371/journal.pone.0079708
17 Wallbillich JJ , Josyula S , Saini U , et al. High glucose-mediated STAT3 activation in endometrial cancer is inhibited by metformin: therapeutic implications for endometrial cancer[J]. PLoS One, 2017, 12 (1): e0170318.
doi: 10.1371/journal.pone.0170318
18 Kaira K , Toyoda M , Shimizu A , et al. Prognostic significance of GRP78/BiP expression in patients with Stage Ⅲ/Ⅳ hypopharyngeal squamous cell carcinoma[J]. Neoplasma, 2016, 63 (3): 477- 483.
doi: 10.4149/319_151002N513
19 Niu ZY , Wang MY , Zhou L , et al. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer[J]. Sci Rep, 2015, 5: 16067.
doi: 10.1038/srep16067
20 Wang XH , Liu BR , Qu B , et al. Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy[J]. Neoplasma, 2011, 58 (2): 158- 171.
doi: 10.4149/neo_2011_02_158
[1] 苏杰,马春梅,赵丽莉,刘岩,邵宏超. miR-204通过内质网应激抑制视网膜母细胞瘤生长作用及机制的研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 105-108.
[2] 黄河,欧阳晖. 下咽癌共病食管癌的高危因素及预后分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 82-86.
[3] 崔晓波. 诱导化疗在局部晚期下咽癌治疗中的意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 10-17.
[4] 滕兴波,曹智,孙海霞,刘宪金,杨伟舟,朱艳,朱玉广. GRP94、EIF2α在原发型闭角性青光眼小梁中的作用研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 115-118.
[5] 黄志刚. CO2激光手术治疗咽喉部肿瘤[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 1-3.
[6] 周华群,张立庆,徐朝琪,姜盼,王愿,刘晓静,董伟达. 姜黄素联合白藜芦醇抑制人头颈部肿瘤细胞系增殖的机制研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 67-72.
[7] 李晓明,宋琦,李红霞,陶振峰,申宇鹏,肖淑芬. 胸大肌肌皮瓣在侵犯下咽晚期头颈鳞癌手术切除术后缺损修复中的应用[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 4-9.
[8] 李文明,魏东敏,孙睿杰,钱晔,刘大昱,解光,雷大鹏,潘新良. 下咽癌侵犯颈段食管的治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 15-19.
[9] 董频,英信江,陈歆维,邓志宏,张少强,於子卫,金斌,孙臻峰,谢晋,祝江才. 新辅助化疗方案尼妥珠单抗联合奈达铂和5-氟尿嘧啶治疗下咽鳞癌初步临床分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 10-14.
[10] 胡文良,郑艳秋,崔晓波,崔彦茹,孙源昊. 下咽癌中差异表达的蛋白激酶及其抑制剂的生物信息学筛选[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 24-28.
[11] 江昌,许承弼,辛丁,鞠洋,李鸿燕,王金月. 下咽癌腋窝淋巴结转移1例及文献回顾[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 90-92.
[12] 郑立友. 中西医结合治疗喉癌下咽癌手术并发咽瘘10例[J]. 山东大学耳鼻喉眼学报, 2012, 26(6): 31-33.
[13] 沈斌,董频,英信江,高尚,李大伟. ABCG2及NF-κB p65在下咽癌中的表达意义[J]. 山东大学耳鼻喉眼学报, 2012, 26(4): 17-20.
[14] 曹汉海1,丁海霞2,彭洪娟3. 多层螺旋CT后处理技术对下咽癌评估的价值[J]. 山东大学耳鼻喉眼学报, 2011, 25(3): 25-27.
[15] 叶婷1,马超2,潘新良1. 下咽癌瘤内淋巴管生成及颈淋巴转移关系的研究[J]. 山东大学耳鼻喉眼学报, 2011, 25(1): 24-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 杨长亮,黄治物,姚行齐,诸勇,孙艺 . 正常气骨导听性脑干反应及其应用[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 9 -13 .
[2] 曹忠良 . 颌面复合伤155例临床分析[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 89 -89 .
[3] 毕景云 . 鼻中隔矫正术后血肿的处理[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 90 -91 .
[4] 刘大昱,潘新良,雷大鹏,许风雷,张立强,栾信庸 . 梨状窝内侧壁癌的手术治疗[J]. 山东大学耳鼻喉眼学报, 2007, 21(1): 8 -11 .
[5] 楼正才 . 掌拳击伤鼓膜损伤机制及临床特点分析[J]. 山东大学耳鼻喉眼学报, 2008, 22(2): 188 -188 .
[6] 刘 艳,刘新义,王金平,李大健 . 后鼓室解剖结构测量观察及临床意义[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 218 -221 .
[7] 赵 敏,王守森,甄泽年,陈贤明,王茂鑫 . 鼻内镜联合显微镜行蝶窦及经蝶鞍区微创手术[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 244 -245 .
[8] 伦 杰,吕心红 . 鼻部脂溢性角化病1例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 252 -252 .
[9] 王红霞,王鹏程 . NSE、S100及GFAP在视网膜母细胞瘤中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 263 -264 .
[10] 黄 方,黄海琼,黄建强,何荷蕃 . 支气管内镜视频监视系统在小儿气管-支气管异物诊治中的应用[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 276 -277 .